330 related articles for article (PubMed ID: 25591984)
1. Metabolic risk in PCOS: phenotype and adiposity impact.
Moran LJ; Norman RJ; Teede HJ
Trends Endocrinol Metab; 2015 Mar; 26(3):136-43. PubMed ID: 25591984
[TBL] [Abstract][Full Text] [Related]
2. Role of obesity and adiposity in polycystic ovary syndrome.
Diamanti-Kandarakis E
Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
[TBL] [Abstract][Full Text] [Related]
4. Adiposity and metabolic dysfunction in polycystic ovary syndrome.
Sam S
Horm Mol Biol Clin Investig; 2015 Feb; 21(2):107-16. PubMed ID: 25781555
[TBL] [Abstract][Full Text] [Related]
5. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
6. Cardiometabolic and reproductive benefits of early dietary energy restriction and voluntary exercise in an obese PCOS-prone rodent model.
Diane A; Kupreeva M; Borthwick F; Proctor SD; Pierce WD; Vine DF
J Endocrinol; 2015 Sep; 226(3):193-206. PubMed ID: 26187902
[TBL] [Abstract][Full Text] [Related]
7. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
Moghetti P; Tosi F; Bonin C; Di Sarra D; Fiers T; Kaufman JM; Giagulli VA; Signori C; Zambotti F; Dall'Alda M; Spiazzi G; Zanolin ME; Bonora E
J Clin Endocrinol Metab; 2013 Apr; 98(4):E628-37. PubMed ID: 23476073
[TBL] [Abstract][Full Text] [Related]
8. The impact of hyperandrogenism in female obesity and cardiometabolic diseases associated with polycystic ovary syndrome.
Barber TM; Vojtechova P; Franks S
Horm Mol Biol Clin Investig; 2013 Sep; 15(3):91-103. PubMed ID: 25436736
[TBL] [Abstract][Full Text] [Related]
9. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
Moran L; Teede H
Hum Reprod Update; 2009; 15(4):477-88. PubMed ID: 19279045
[TBL] [Abstract][Full Text] [Related]
10. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
[TBL] [Abstract][Full Text] [Related]
11. Cardiometabolic Risks in Polycystic Ovary Syndrome: Non-Traditional Risk Factors and the Impact of Obesity.
Chiu WL; Boyle J; Vincent A; Teede H; Moran LJ
Neuroendocrinology; 2017; 104(4):412-424. PubMed ID: 28006770
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
Daan NM; Louwers YV; Koster MP; Eijkemans MJ; de Rijke YB; Lentjes EW; Fauser BC; Laven JS
Fertil Steril; 2014 Nov; 102(5):1444-1451.e3. PubMed ID: 25239303
[TBL] [Abstract][Full Text] [Related]
13. The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk.
Amato MC; Verghi M; Galluzzo A; Giordano C
Hum Reprod; 2011 Jun; 26(6):1486-94. PubMed ID: 21447694
[TBL] [Abstract][Full Text] [Related]
14. Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about.
Shorakae S; Boyle J; Teede H
Intern Med J; 2014 Aug; 44(8):720-6. PubMed ID: 24909750
[TBL] [Abstract][Full Text] [Related]
15. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
16. Mouse models to study polycystic ovary syndrome: a possible link between metabolism and ovarian function?
van Houten EL; Visser JA
Reprod Biol; 2014 Mar; 14(1):32-43. PubMed ID: 24607253
[TBL] [Abstract][Full Text] [Related]
17. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM
Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping.
Caserta D; Adducchio G; Picchia S; Ralli E; Matteucci E; Moscarini M
Gynecol Endocrinol; 2014 Jun; 30(6):397-402. PubMed ID: 24552422
[TBL] [Abstract][Full Text] [Related]
19. Periodontal disease in polycystic ovary syndrome.
Dursun E; Akalın FA; Güncü GN; Çınar N; Aksoy DY; Tözüm TF; Kılınc K; Yıldız BO
Fertil Steril; 2011 Jan; 95(1):320-3. PubMed ID: 20800834
[TBL] [Abstract][Full Text] [Related]
20. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
Hutchison SK; Stepto NK; Harrison CL; Moran LJ; Strauss BJ; Teede HJ
J Clin Endocrinol Metab; 2011 Jan; 96(1):E48-56. PubMed ID: 20926534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
